The earlier use of this study’s survey revealed that the life expectancy of RPGN patients in Japan has improved together with a reduction of the intensity of treatment from conventional therapy since 2002, as RPGN is characterized by a high proportion of elderly patients and MPO-ANCA-positive patients, and approx. one-half of all deaths were caused by infections. This evidence concerns the gene MPO and infection.